ROBO2 and myelodysplastic syndrome: In summary, this is the first report of whole-exome sequencing of paired samples from MDS cases with disease progression and the first description of recurrent, validated ROBO1 and ROBO2 mutations in MDS that confer a worse clinical outcome.